MetaCap

Tempest Therapeutics Inc. (TPST)

NASDAQ: TPSTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

0.7914+0.0039 (+0.50%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

TPST stock chart

Technical analysis

Key statistics

All statistics
Market cap
$13.37M
EPS (TTM)
-$3.98
52-week range
0.743 – 12.23
Day range
0.7515 – 0.8199
Volume / Avg
305.21K / 2.63M
Beta
—
Next earnings
Nov 4, 2026

52-week range

$0.743$12.23

TPST stock today

Tempest Therapeutics (TPST) closed at $0.7914 on Oct 7, up 0.50% (+$0.0039), versus the S&P 500's 0.22% decline. Trading was light, with 305.21K shares changing hands, about 12% of the average daily volume. Shares are 93.5% below their 52-week high of $12.23, set on Oct 15, 2025 and 6.5% above the 52-week low of $0.743, near the bottom of the past year's range.

TPST is down 72.4% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 92.6%. Tempest Therapeutics has posted a net loss over the last twelve months (EPS of -$3.98), so its P/E ratio is not meaningful. Tempest Therapeutics's next earnings report is expected on Nov 4, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Tempest Therapeutics

Company profile
Industry
Biotechnology: Pharmaceutical Preparations

Earnings

Earnings history
Next report
Nov 4, 2026
EPS estimate
$-0.32

Tempest Therapeutics peers

Health Care sector
TPST peer companies
CompanyPrice% ChgMarket capCompare
LTRNLantern Pharma Inc.0.91-4.58%$13.59Mvs TPST
BFRGBullfrog AI Holdings Inc.0.7086+2.84%$13.14Mvs TPST
CTXRCitius Pharmaceuticals Inc.0.5011+4.24%$13.76Mvs TPST
BFRIBiofrontera Inc.0.9354+0.36%$13.89Mvs TPST
LSTALisata Therapeutics Inc.1.17-3.31%$12.64Mvs TPST
CLRBCellectar Biosciences Inc.1.510.00%$14.27Mvs TPST
HINDVyome Holdings Inc.2.04-0.97%$14.32Mvs TPST
BIVIBioVie Inc. Class A1.40-2.78%$12.16Mvs TPST

Indexes, lists and sector

Tempest Therapeutics stock FAQ

What is Tempest Therapeutics's stock price today?

TPST last traded at $0.7914 as of Oct 7, 4:00 PM EDT, up 0.50% on the day. Prices are delayed at least 15 minutes.

Does Tempest Therapeutics pay a dividend?

No. Tempest Therapeutics does not currently pay a regular cash dividend.

When is Tempest Therapeutics's next earnings date?

Tempest Therapeutics is expected to report earnings on Wednesday, November 4, 2026. Analysts expect EPS of $-0.32.

Has TPST ever split its stock?

Yes. The most recent TPST stock split was a 1-for-13 split on Apr 9, 2025, one of 3 splits on record.

What is the TPST 52-week high?

The 52-week high for TPST is $12.23 and the 52-week low is $0.743. The stock is currently 93.5% below its high.

Compare TPST